Pregnancy Clinical Trial
Official title:
Sleep Self-management in Pregnancy Using a Personalized Health Monitoring Device
Pregnancy-associated sleep disorders are a common acute experience in pregnancy experienced
by up to 82% of women. Sleep disorders are associated with increased risk for pre-eclampsia,
gestational diabetes, longer labor, cesarean birth, and postpartum depression, and are higher
among pregnant women of lower socioeconomic status. Traditional clinical management of sleep
disorders in pregnancy includes education and counseling on sleep hygiene and sleep
positioning, dietary modifications, relaxation, iron supplementation, weight management, and
physical activity, yet education-based behavioral interventions show minimal effectiveness
for improving sleep among pregnant women. These methods typically do not incorporate
objective self-monitoring, which is an important behavior change technique. In pregnancy,
objective self-monitoring on a day-to-day basis is particularly important as sleep disorders
may worsen as pregnancy progresses.
Computer-based personalized health monitoring (PHM) devices may serve as an effective tool
with which pregnant women can self-manage sleep through incorporation of regular feedback.
This strategy may be beneficial not only for women with pregnancy-associated sleep disorders
but also for pregnant women with less severe sleep disruptions that experience daytime
sleepiness, fatigue, and decreased quality of life. PHM devices have been used to promote
weight loss, diet, and physical activity changes but no studies have specifically targeted
sleep among pregnant women. The purpose of this pilot study is to establish the feasibility
and acceptability of conducting a 12-week intervention for sleep self-management with
pregnant women using a PHM device, in order to refine the intervention for a larger,
randomized trial.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03442582 -
Afluria Pregnancy Registry
|
||
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
Completed |
NCT04548102 -
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman
|
N/A | |
Completed |
NCT03218956 -
Protein Requirement During Lactation
|
N/A | |
Completed |
NCT02191605 -
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
|
N/A | |
Completed |
NCT02223637 -
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
|
||
Recruiting |
NCT06049953 -
Maternal And Infant Antipsychotic Study
|
||
Completed |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
Not yet recruiting |
NCT06336434 -
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05412238 -
Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months
|
N/A | |
Not yet recruiting |
NCT04786587 -
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
|
||
Not yet recruiting |
NCT05028387 -
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
|
||
Completed |
NCT02683005 -
Study of Hepatitis C Treatment During Pregnancy
|
Phase 1 | |
Completed |
NCT02783170 -
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
|
Phase 4 | |
Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
Recruiting |
NCT02564250 -
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
|
N/A | |
Completed |
NCT02566005 -
A Randomized Comparison of Transcervical Foley Bulb With Vaginal Misoprostol to Vaginal Misoprostol Alone for Induction of Labor
|
N/A |